Skip to content

Re-Rehabilitation in Chronic Obstrctive Pulmonary Disease

The Effect of Re-Rehabilitation in Patients With COPD

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04009538
Enrollment
22
Registered
2019-07-05
Start date
2013-01-31
Completion date
2019-03-31
Last updated
2019-07-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Copd, Rehabilitation; Tobacco Use, Smoking, Smoking Cessation

Keywords

copd, smoking, Smoking Cessation, Rehabilitation; Tobacco Use

Brief summary

Patients with COPD who participated in the second rehabilitation program in the Pulmonary Rehabilitation unit will be included in the study. Pulmonary function tests, arterial blood gases, mMRC dyspnea perception, 6-minute walking distance, disease-specific (SGRQ) quality of life and hospital anxiety depression scale values will be compared.

Detailed description

Pulmonary rehabilitation (PR) program in patients with COPD reduces dyspnea perception, increases exercise capacity, improves quality of life, and reduces psychological symptoms. Unfortunately, these gains are not permanent, but disappear within 12-24 months. The aim of this study is to compare the gains of the second PR program with the first program. Patients with COPD who participated in the second rehabilitation program in the Pulmonary Rehabilitation unit will be included in the study. Pulmonary function tests, arterial blood gases, mMRC dyspnea perception, 6-minute walking distance, disease-specific (SGRQ) quality of life and hospital anxiety depression scale values will be compared.

Interventions

OTHERRehabilitation program

exercise program twice a week

Sponsors

Izmir Katip Celebi University
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Intervention model description

COPD patient participated first and second rehabilitation program

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Above 18 years * Completed PR program

Exclusion criteria

\-

Design outcomes

Primary

MeasureTime frameDescription
Exercise Capacity6 minutesSix minutes walk test

Secondary

MeasureTime frameDescription
Respiratory Functions30 minutesPulmonary Function Test
Dyspnea Sensation5 minutesWe used Modified Medical Research Council (MMRC) dyspnea scale, which consists of 5 items ranging between 1 and 5, to determine the severity of patients' shortness of breath. The score 1 represents the best level, where the score 5 indicates the poorest.
Disease Specific Quality of Life20 minutesWe used St. George's Respiratory Questionnaire (SGRQ) to determine disease-specific quality of life. At this scale, high scores define worsened disease and increased symptoms.
Anxiety and Depression20 minutesHospital Anxiety and Depression (HAD) Inventory was used for assessment of anxiety and depression. In this scale; scores of anxiety and depression are calculated separately. The maximum score for both is 21 and high scores correspond to high degree anxiety and depression. Cut-off scores for anxiety and depression were determined as 10/11 and 7/8 respectively.

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026